ABOUT

Oxford Cannabinoid Technologies (OCT) is a pharmaceutical company focused on developing next-generation prescription cannabinoid medicines for the multi-billion dollar pain market. OCT aims to lead the global development of licensed prescription medicines targeting the endocannabinoid system to create safe prescription drugs for serious human illnesses, especially chronic pain.

We have worked with them to support their bold transition, both strategically and creatively, developing a brand positioning strategy designed to effectively introduce, establish, and communicate the USPs and benefits of OCT.

We crafted a strategic framework that served as the cornerstone of OCT's brand proposition. The strategy needed to emphasise the evolution and growth of OCT, while articulating its distinctive core principles and future aspirations.

This was to be achieved through the development of a fresh brand identity, a strategic communications plan, brand assets, brand literature and a refreshed website.

The framework guided our creative strategy, allowing us to establish a unique and memorable brand identity, create valuable brand assets, and devise an effective communications strategy.

We developed a brand book that now acts as a guide for all brand communications. These guides enabled us to deliver an engaging Annual Report and a confident, modern website, both infused with the new brand language and core, creative aesthetics. The new website boasts a distinctive and memorable design along with a user-friendly interface.